|
Name |
Cyclopentanone, 3,3,4-trimethyl-4-(4-methylphenyl)-
|
| Molecular Formula | C15H20O | |
| IUPAC Name* |
3,3,4-trimethyl-4-(4-methylphenyl)cyclopentan-1-one
|
|
| SMILES |
CC1=CC=C(C=C1)C2(CC(=O)CC2(C)C)C
|
|
| InChI |
InChI=1S/C15H20O/c1-11-5-7-12(8-6-11)15(4)10-13(16)9-14(15,2)3/h5-8H,9-10H2,1-4H3
|
|
| InChIKey |
MTWLTRIBMFLOIL-UHFFFAOYSA-N
|
|
| Synonyms |
25090-79-3; Cyclopentanone, 3,3,4-trimethyl-4-(4-methylphenyl)-; 3,3,4-Trimethyl-4-(4-methylphenyl)cyclopentanone; SCHEMBL2946642; DTXSID50342624; 3,3,4-trimethyl-4-(p-tolyl)-cyclopentan-1-one; 3,3,4-Trimethyl-4-(4-methylphenyl)cyclopentanone #
|
|
| CAS | 25090-79-3 | |
| PubChem CID | 583402 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 216.32 | ALogp: | 3.5 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 2 |
| Heavy Atoms: | 16 | QED Weighted: | 0.682 |
| Caco-2 Permeability: | -4.753 | MDCK Permeability: | 0.00002070 |
| Pgp-inhibitor: | 0.966 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.826 | Plasma Protein Binding (PPB): | 79.42% |
| Volume Distribution (VD): | 1.477 | Fu: | 24.76% |
| CYP1A2-inhibitor: | 0.271 | CYP1A2-substrate: | 0.883 |
| CYP2C19-inhibitor: | 0.813 | CYP2C19-substrate: | 0.948 |
| CYP2C9-inhibitor: | 0.561 | CYP2C9-substrate: | 0.826 |
| CYP2D6-inhibitor: | 0.047 | CYP2D6-substrate: | 0.859 |
| CYP3A4-inhibitor: | 0.465 | CYP3A4-substrate: | 0.554 |
| Clearance (CL): | 9.217 | Half-life (T1/2): | 0.317 |
| hERG Blockers: | 0.061 | Human Hepatotoxicity (H-HT): | 0.357 |
| Drug-inuced Liver Injury (DILI): | 0.171 | AMES Toxicity: | 0.02 |
| Rat Oral Acute Toxicity: | 0.091 | Maximum Recommended Daily Dose: | 0.036 |
| Skin Sensitization: | 0.121 | Carcinogencity: | 0.136 |
| Eye Corrosion: | 0.152 | Eye Irritation: | 0.733 |
| Respiratory Toxicity: | 0.168 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000772 | ![]() |
0.615 | D0M6DO | ![]() |
0.286 | ||
| ENC001317 | ![]() |
0.593 | D08EOD | ![]() |
0.273 | ||
| ENC000233 | ![]() |
0.354 | D08KVZ | ![]() |
0.270 | ||
| ENC000199 | ![]() |
0.346 | D0X0WU | ![]() |
0.270 | ||
| ENC000457 | ![]() |
0.340 | D0N0RU | ![]() |
0.270 | ||
| ENC000221 | ![]() |
0.333 | D02WCI | ![]() |
0.258 | ||
| ENC000086 | ![]() |
0.327 | D09BHB | ![]() |
0.250 | ||
| ENC000146 | ![]() |
0.302 | D0T1WN | ![]() |
0.244 | ||
| ENC000796 | ![]() |
0.292 | D06OIV | ![]() |
0.243 | ||
| ENC002065 | ![]() |
0.284 | D06GIP | ![]() |
0.241 | ||